{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:41:37Z","timestamp":1772901697601,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10067-021-05729-0","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T14:03:06Z","timestamp":1617890586000},"page":"4749-4757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-5673","authenticated-orcid":false,"given":"Grigorios T.","family":"Sakellariou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Tsifountoudis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Periklis","family":"Vounotrypidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"5729_CR1","first-page":"579","volume":"56","author":"B Fourni\u00e9","year":"1989","unstructured":"Fourni\u00e9 B, Viraben R, Durroux R, Lassoued S, Gay R, Fourni\u00e9 A (1989) L\u2019onycho-pachydermo-periostite psoriasique du gros orteil. Etude anatomo-clinique et approche physiopathogenique a propos de 4 observations. Rev Rhum Mal Osteoartic 56:579\u2013582","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"5729_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/archderm.1996.03890260078012","volume":"132","author":"AM Boisseau-Garsaud","year":"1996","unstructured":"Boisseau-Garsaud AM, Beylot-Barry M, Doutre MS, Beylot C, Baran R (1996) Psoriatic onycho-pachydermo-periostitis. A variant of psoriatic distal interphalangeal arthritis? Arch Dermatol 132:176\u2013180","journal-title":"Arch Dermatol"},{"key":"5729_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/archderm.136.7.925-b","volume":"136","author":"CS Jury","year":"2000","unstructured":"Jury CS, Fleming C, Kemmett D (2000) Severe nail dystrophy associated with painful fingertips. Diagnosis: psoriatic onychopachydermoperiostitis (POPP). Arch Dermatol 136:925\u2013930","journal-title":"Arch Dermatol"},{"key":"5729_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1046\/j.1365-2133.2000.03802.x","volume":"143","author":"A Bauz\u00e1","year":"2000","unstructured":"Bauz\u00e1 A, Redondo P, Aquerreta D (2000) Psoriatic onycho-pachydermo periostitis: treatment with methotrexate. Br J Dermatol 143:901\u2013902","journal-title":"Br J Dermatol"},{"key":"5729_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00393-002-0314-9","volume":"61","author":"MM Kroiss","year":"2000","unstructured":"Kroiss MM, Vogt T, Finkenzeller T, Landthaler M, Stolz W (2000) Psoriatische onycho-pachydermo-periostitis. Z Rheumatol 61:598\u2013600","journal-title":"Z Rheumatol"},{"key":"5729_CR6","first-page":"CS27","volume":"12","author":"T Ochiai","year":"2006","unstructured":"Ochiai T, Washio H, Shiraiwa H, Takei M, Sawada S (2006) Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate. Med Sci Monit 12:CS27\u2013CS30","journal-title":"Med Sci Monit"},{"key":"5729_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1365-2230.2011.04328.x","volume":"37","author":"M Watanabe","year":"2012","unstructured":"Watanabe M, Ujiie H, Iitani MM, Abe R, Shimizu H (2012) Psoriatic onycho-pachydermo-periostitis progressing to generalized pustular psoriasis. Clin Exp Dermatol 37:683\u2013685","journal-title":"Clin Exp Dermatol"},{"key":"5729_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4103\/0019-5154.84743","volume":"56","author":"M Bertero","year":"2011","unstructured":"Bertero M, Seia Z, Grande CD, Musso L, Palazzini S (2011) Painful 20 fingers' onychodistrophy. Indian J Dermatol 56:415\u2013417","journal-title":"Indian J Dermatol"},{"key":"5729_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5606\/ArchRheumatol.2016.5682","volume":"31","author":"S S\u00fczen \u00d6zbayrak","year":"2016","unstructured":"S\u00fczen \u00d6zbayrak S, Binay Safer V, \u00d6zbayrak M (2016) A rapidly progressive variant of psoriatic arthritis: psoriatic onycho-pachydermo-periostitis. Arch Rheumatol 31:94\u201397","journal-title":"Arch Rheumatol"},{"key":"5729_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/art.20763","volume":"52","author":"T Bongartz","year":"2005","unstructured":"Bongartz T, H\u00e4rle P, Friedrich S, Karrer S, Vogt T, Seitz A, M\u00fcller-Ladner U (2005) Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab. Arthritis Rheum 52:280\u2013282","journal-title":"Arthritis Rheum"},{"key":"5729_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1365-2133.2005.06867.x","volume":"153","author":"M Dans","year":"2005","unstructured":"Dans M, Hivnor C, van Voorhees AS (2005) Psoriatic onychopachydermoperiostitis: improvement with etanercept. Br J Dermatol 153:858\u2013859","journal-title":"Br J Dermatol"},{"key":"5729_CR12","first-page":"2077","volume":"35","author":"MA Kapusta","year":"2008","unstructured":"Kapusta MA, Dumont C (2008) Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents. J Rheumatol 35:2077\u20132080","journal-title":"J Rheumatol"},{"key":"5729_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1684\/ejd.2015.2616","volume":"25","author":"D Watabe","year":"2015","unstructured":"Watabe D, Endoh K, Maeda F, Akasaka T, Endoh M (2015) Childhood-onset psoriatic onycho-pachydermo-periostitis treated successfully with infliximab. Eur J Dermatol 25:506\u2013508","journal-title":"Eur J Dermatol"},{"key":"5729_CR14","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1111\/ajd.12667","volume":"59","author":"K Horie","year":"2018","unstructured":"Horie K, Fujita Y, Hoshina D, Abe R, Shimizu H (2018) Rapid response to clinical symptoms in early psoriatic onycho-pachydermo-periostitis treated with infliximab. Australas J Dermatol 59:e78\u2013e79","journal-title":"Australas J Dermatol"},{"key":"5729_CR15","first-page":"373","volume":"118","author":"MC Marguery","year":"1991","unstructured":"Marguery MC, Baran R, Pages M, Bazex J (1991) Acropachydermie psoriasique. Ann Dermatol Venereol 118:373\u2013376","journal-title":"Ann Dermatol Venereol"},{"key":"5729_CR16","first-page":"229","volume":"120","author":"MD Pontville","year":"1993","unstructured":"Pontville MD, Dompmartin A, Raucourt SD, Marco M, R\u00e9mond B, Leroy D (1993) Onycho-pachydermo-periostite psoriasique. Ann Dermatol Venereol 120:229\u2013232","journal-title":"Ann Dermatol Venereol"},{"key":"5729_CR17","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.21370","volume":"52","author":"A Tsubota","year":"2005","unstructured":"Tsubota A, Abe R, Shibaki A (2005) Clinical images: Drumstick-like fingers indicating psoriatic onycho-pachydermo periostitis. Arthritis Rheum 52:2954","journal-title":"Arthritis Rheum"},{"key":"5729_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s001050050618","volume":"48","author":"K Schr\u00f6der","year":"1997","unstructured":"Schr\u00f6der K, Goerdt S, Sieper J, Krasagakis K, Almond-Roesler B, Orfanos CE (1997) Psoriatische onycho-pachydermo-periostitis (POPP). Hautarzt 48:500\u2013503","journal-title":"Hautarzt"},{"key":"5729_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s001050050839","volume":"49","author":"A Ziemer","year":"1998","unstructured":"Ziemer A, Heider M, G\u00f6ring HD (1998) Psoriasiforme onychopachydermoperiostitis der gro\u00dfzehen: das OP3GO-syndrom. Hautarzt 49:859\u2013862","journal-title":"Hautarzt"},{"key":"5729_CR20","first-page":"11","volume":"7","author":"JS Dosik","year":"2001","unstructured":"Dosik JS (2001) Psoriatic onycho-pachydermo-periostitis. Dermatol Online J 7:11","journal-title":"Dermatol Online J"},{"key":"5729_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00393-002-0352-3","volume":"61","author":"HJ Anders","year":"2002","unstructured":"Anders HJ, Sanden S, Kr\u00fcger K (2002) Psoriatische onycho-pachydermo- periostitis. Z Rheumatol 61:601\u2013604","journal-title":"Z Rheumatol"},{"key":"5729_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1468-3083.2005.01276.x","volume":"19","author":"P Fietta","year":"2005","unstructured":"Fietta P, Manganelli P (2005) Childhood onset of psoriatic onycho-pachydermo-periostitis (POPP). J Eur Acad Dermatol Venereol 19:780\u2013782","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5729_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10067-006-0322-2","volume":"26","author":"P Fietta","year":"2007","unstructured":"Fietta P, Manganelli P (2007) Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP). Clin Rheumatol 26:93\u201394","journal-title":"Clin Rheumatol"},{"key":"5729_CR24","first-page":"20","volume":"13","author":"M Srivastava","year":"2007","unstructured":"Srivastava M, Solomon G, Strober B (2007) Psoriatic onycho-pachydermo periostitis. Dermatol Online J 13:20","journal-title":"Dermatol Online J"},{"key":"5729_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7547\/0980140","volume":"99","author":"JM Mahoney","year":"2009","unstructured":"Mahoney JM, Scott R (2009) Psoriatic onychopachydermoperiostitis (POPP): a perplexing case study. J Am Podiatr Med Assoc 99:140\u2013143","journal-title":"J Am Podiatr Med Assoc"},{"key":"5729_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4103\/0378-6323.98088","volume":"78","author":"B Vasudevan","year":"2012","unstructured":"Vasudevan B, Verma R, Pragasam V, Dabbas D (2012) Unilateral psoriatic onychopachydermoperiostitis. Indian J Dermatol Venereol Leprol 78:499\u2013501","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"5729_CR27","first-page":"86","volume":"23","author":"C-C Chan","year":"2005","unstructured":"Chan C-C, Tsai T-F (2005) Psoriatic onycho-pachydermo-periostitis. Dermatol Sin 23:86\u201390","journal-title":"Dermatol Sin"},{"key":"5729_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/03009741003604559","volume":"39","author":"TJ Love","year":"2010","unstructured":"Love TJ, Gudjonsson JE, Valdimarsson H, Gudbjornsson B (2010) Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study. Scand J Rheumatol 39:299\u2013302","journal-title":"Scand J Rheumatol"},{"key":"5729_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3899\/jrheum.180796","volume":"46","author":"A Antony","year":"2019","unstructured":"Antony A, Allard A, Rambojun A, Lovell CR, Shaddick G, Robinson G et al (2019) Psoriatic nail dystrophy is associated with erosive disease in the distal interphalangeal joints in psoriatic arthritis: a retrospective cohort study. J Rheumatol 46:1097\u20131102","journal-title":"J Rheumatol"},{"key":"5729_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/art.21736","volume":"54","author":"AL Tan","year":"2006","unstructured":"Tan AL, Grainger AJ, Tanner SF, Emery P, McGonagle D (2006) A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum 54:1328\u20131333","journal-title":"Arthritis Rheum"},{"key":"5729_CR31","first-page":"1315","volume":"33","author":"R Scarpa","year":"2006","unstructured":"Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A et al (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33:1315\u20131319","journal-title":"J Rheumatol"},{"key":"5729_CR32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3899\/jrheum.111118","volume":"39","author":"N Dalbeth","year":"2012","unstructured":"Dalbeth N, Pui K, Lobo M, Doyle A, Jones PB, Taylor WJ, McQueen FM (2012) Nail disease in psoriatic arthritis: distal phalangeal bone edema detected by magnetic resonance imaging predicts development of onycholysis and hyperkeratosis. J Rheumatol 39:841\u2013843","journal-title":"J Rheumatol"},{"key":"5729_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000343607","volume":"225","author":"SZ Aydin","year":"2015","unstructured":"Aydin SZ, Castillo-Gallego C, Ash ZR, Marzo-Ortega H, Emery P, Wakefield RJ, Wittmann M, McGonagle D (2015) Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology 225:231\u2013235","journal-title":"Dermatology"},{"key":"5729_CR34","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/jdv.15035","volume":"32","author":"P Moya Alvarado","year":"2018","unstructured":"Moya Alvarado P, Ro\u00e9 Crespo E, Mu\u00f1oz-Garza FZ, L\u00f3pez-Ferrer A, Laiz Alonso A, Vilarrassa Rull E, Casademont I, Pou J, Puig Sanz L (2018) Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease. J Eur Acad Dermatol Venereol 32:1728\u20131736","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5729_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/rheumatology\/kel214","volume":"46","author":"AL Tan","year":"2007","unstructured":"Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, McGonald D (2007) The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis\u2013a high-resolution MRI and histological study. Rheumatology (Oxford) 46:253\u2013256","journal-title":"Rheumatology (Oxford)"},{"key":"5729_CR36","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/bjd.17351","volume":"181","author":"K Reich","year":"2019","unstructured":"Reich K, Sullivan J, Arenberger P, Mrowietz U, Jazayeri S, Augustin M, Parneix A, Regnault P, You R, Milutinovic M (2019) Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial. Br J Dermatol 181:954\u2013966","journal-title":"Br J Dermatol"},{"key":"5729_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/jdv.14033","volume":"31","author":"P van de Kerkhof","year":"2016","unstructured":"van de Kerkhof P, Guenther L, Gottlieb AB, Sebastian M, Wu JJ, Foley P et al (2016) Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3. J Eur Acad Dermatol Venereol 31:477\u2013482","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5729_CR38","first-page":"890","volume":"77","author":"P Mease","year":"2018","unstructured":"Mease P, van der Heijde D, Landew\u00e9 R, Mpofu S, Rahman P, Tahir H, Singhal A, Boettcher E, Navarra S, Meiser K, Readie A, Pricop L, Abrams K (2018) Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study. Ann Rheum Dis 77:890\u2013897","journal-title":"Ann Rheum Dis"},{"key":"5729_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"PJ Mease","year":"2017","unstructured":"Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD, SPIRIT-P1 Study Group (2017) Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-na\u00efve patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann Rheum Dis 76:79\u201387","journal-title":"Ann Rheum Dis"},{"key":"5729_CR40","doi-asserted-by":"publisher","first-page":"e000599","DOI":"10.1136\/rmdopen-2017-000599","volume":"4","author":"Z Ash","year":"2018","unstructured":"Ash Z, Tan AL, Hodgson RJ, Grainger A, Marzo-Ortega H, McGonagle DG (2018) MRI of psoriatic nail disease pre- and post-TNF inhibitor therapy shows persistent subclinical inflammation after 6 months despite good clinical response. RMD Open 4:e000599","journal-title":"RMD Open"},{"key":"5729_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/annrheumdis-2016-209334","volume":"76","author":"SM Thorarensen","year":"2017","unstructured":"Thorarensen SM, Lu N, Ogdie A, Gelfand JM, Choi HK, Love TJ (2017) Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann Rheum Dis 76:521\u2013525","journal-title":"Ann Rheum Dis"},{"key":"5729_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/ard.2003.018184","volume":"64","author":"JE Brockbank","year":"2005","unstructured":"Brockbank JE, Stein M, Schentag CT, Gladman DD (2005) Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 64:188\u2013190","journal-title":"Ann Rheum Dis"},{"key":"5729_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, Armaka M, Verhoye M, van der Linden A, Achten R, Lories RJ, Elewaut D (2014) Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis 73:437\u2013445","journal-title":"Ann Rheum Dis"},{"key":"5729_CR44","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","volume":"68","author":"LC Coates","year":"2016","unstructured":"Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW et al (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheum 68:1060\u20131071","journal-title":"Arthritis Rheum"},{"key":"5729_CR45","doi-asserted-by":"crossref","unstructured":"Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, Primdahl J, McGonagle DG, Aletaha D, Balanescu A, Balint PV, Bertheussen H, Boehncke WH, Burmester GR, Canete JD, Damjanov NS, Kragstrup TW, Kvien TK, Landew\u00e9 RBM, Lories RJU, Marzo-Ortega H, Poddubnyy D, Rodrigues Manica SA, Schett G, Veale DJ, van den Bosch FE, van der Heijde D, Smolen JS (2020) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 79:700\u2013712","DOI":"10.1136\/annrheumdis-2020-217159"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05729-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T21:04:16Z","timestamp":1698872656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05729-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5729"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05729-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"21 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Informed consent was obtained from the patient for publication of material relating to him.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}